Iain Stuart
CIK 1727756 · CHIEF SCIENTIFIC OFFICER · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$72.9K
Companies
3
Total Filings
43
Lifetime Open-Market Net
-$27.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | CHIEF SCIENTIFIC OFFICER | 112,363 | $0.65 | $72.9K | $0 | 28 | 2026-04-02 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Chief Scientific Officer | 291,018 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Chief Scientific Officer | 103,636 | — | — | -$27.1K | 9 | 2020-02-24 |
Recent Filings · Page 4 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-07 | VYNE Therapeutics Inc. (MNLO) Delisted | Mixed | +121,449 | -$5.3K | EDGAR |
| 2020-04-02 | VYNE Therapeutics Inc. (MNLO) Delisted | Tax (F) | −1,940 | -$5.2K | EDGAR |
| 2020-03-11 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +61,392 | $0 | EDGAR |
| 2020-03-11 | — | Disp (D) | −103,636 | $0 | |
| 2020-02-24 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +41,299 | $0 | EDGAR |
| 2020-01-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Tax (F) | −514 | -$1.7K | EDGAR |
| 2019-10-02 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Tax (F) | −673 | -$2.1K | EDGAR |
| 2019-07-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Sell (S) | −951 | -$2.2K | EDGAR |
| 2019-04-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Sell (S) | −1,696 | -$6.4K | EDGAR |
| 2019-01-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | +32,569 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.